Lars Børty (Lars Børty Nielsen)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Multiple Myeloma

Ejection Fraction

Bioinformatics Analysis

Top Venues

Future oncology (London, England)

European journal of haematology

The European journal of health economics : HEPAC : health economics in prevention and care

This page only lists publications with an associated author ORCID identifier.

Publications

Lise Dueholm Bertelsen, Lars Børty, Heidi Søgaard Christensen, Martin Bøgsted, Henrik Gregersen, Robert Schou Pedersen, Anja Klostergaard, Brian Iversen Schnack, Per Trøllund Pedersen, Niels Abildgaard, Niels Emil Ulrich Hermansen, Annette Juul Vangsted, Marianne Tang Severinsen
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation. European journal of haematology (2022)
Lars Børty, Rasmus Froberg Brøndum, Heidi S Christensen, Charles Vestereghem, Marianne Tang Severinsen, Søren Paaske Johnsen, Lars Holger Ehlers, Ursula Falkmer, Laurids Østergaard Poulsen, Martin Bøgsted
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Rasmus Froberg Brøndum, Anne Sig Sørensen, Lars Børty, Charles Vestereghem, Anne S Rytter, Marlene M Nielsen, Marianne Tang Severinsen, Paw Jensen, Henrik Gregersen, Tarec Christoffer El-Galaly, Karen Dybkær, Lars Holger Ehlers, Martin Bøgsted, Anne Stidsholt Roug
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system. Future oncology (London, England) 17 (25) (2021)